Corin is a novel and potent inhibitor of histone lysine specific demethylase (LSD1) and histone deacetylase (HDAC) with anticancer effects. It inhibits LSD1 and HDAC1 with a Ki(inact) of 110 nM for LSD1 and an IC50 of 147 nM for HDAC1.
Physicochemical Properties
| Molecular Formula | C26H28N4O2 |
| Molecular Weight | 428.526125907898 |
| Exact Mass | 428.221 |
| CAS # | 1808113-09-8 |
| PubChem CID | 134828251 |
| Appearance | Light yellow to yellow solid powder |
| LogP | 2.8 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Heavy Atom Count | 32 |
| Complexity | 625 |
| Defined Atom Stereocenter Count | 2 |
| SMILES | O=C(CCCC1C=CC(C(NC2C=CC=CC=2N)=O)=CC=1)NC1C=CC(=CC=1)C1CC1N |
| InChi Key | TYTLARZOLKJSJU-JTHBVZDNSA-N |
| InChi Code | InChI=1S/C26H28N4O2/c27-22-5-1-2-6-24(22)30-26(32)19-10-8-17(9-11-19)4-3-7-25(31)29-20-14-12-18(13-15-20)21-16-23(21)28/h1-2,5-6,8-15,21,23H,3-4,7,16,27-28H2,(H,29,31)(H,30,32)/t21-,23+/m0/s1 |
| Chemical Name | 4-[4-[4-[(1S,2R)-2-aminocyclopropyl]anilino]-4-oxobutyl]-N-(2-aminophenyl)benzamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Through the CoREST ternary complex, corin prevents semisynthetic, recombinant nucleosomes from being deacetylated. HDAC1 activity is irreversibly inhibited by corin. Corin seems to be more potent than MS-275 (EC50 of 95 nM against EC50 of 420 nM for MS-275) and causes cellular H3K9 necking more successfully. It's interesting to note that, in contrast to MS-275 (1 μM), Corin (1 μM) is not harmful to primary human melanocytes[1]. |
| References |
[1]. Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors. Nat Commun. 2018 Jan 4;9(1):53. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~233.36 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.83 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.83 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3336 mL | 11.6678 mL | 23.3356 mL | |
| 5 mM | 0.4667 mL | 2.3336 mL | 4.6671 mL | |
| 10 mM | 0.2334 mL | 1.1668 mL | 2.3336 mL |